The duration of anthracycline infusion should be at least one hour in children with cancer: A clinical practice guideline

Anthracycline Cardiotoxicity Working Group

Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenpeer review

11 Citaten (Scopus)

Samenvatting

We aimed to provide recommendations on the infusion duration of anthracycline chemotherapy agents in children with cancer. This study also serves as a practice example of the essential steps that need to be taken when using a previously published systematic review to develop a high-quality clinical practice guideline. Although evidence was scarce and included adult studies, the panel was able (using the Grading of Recommendations Assessment, Development and Evaluation evidence-to-decision framework) to recommend in favor of an anthracycline infusion duration of at least 1 hr (strong recommendation, very low to moderate quality of evidence). Recommending a precise optimal prolonged infusion duration was currently not possible.

Originele taal-2Engels
Artikelnummere26867
TijdschriftPediatric blood & cancer
Volume65
Nummer van het tijdschrift2
DOI's
StatusGepubliceerd - feb. 2018
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'The duration of anthracycline infusion should be at least one hour in children with cancer: A clinical practice guideline'. Samen vormen ze een unieke vingerafdruk.

Citeer dit